NATURE’S SUNSHINE PRODUCTS, INC. Deferred Income Tax Assets, Net
NATURE’S SUNSHINE PRODUCTS, INC. (NATR) had Deferred Income Tax Assets, Net of $19.50 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:DeferredIncomeTaxAssetsNet · last filed 2026-08-06
- 2026-06-30: Deferred Income Tax Assets, Net $19.50M.
- 2026-03-31: Deferred Income Tax Assets, Net $19.41M.
- 2025-12-31: Deferred Income Tax Assets, Net $20.07M.
- 2025-09-30: Deferred Income Tax Assets, Net $20.36M.
| Period end | Deferred Income Tax Assets, Net |
|---|---|
| 2026-06-30 | $19.50M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $19.41M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $20.07M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $20.36M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $21.41M 10-Q · filed 2025-07-31 |
| 2025-03-31 | $20.02M 10-Q · filed 2025-05-06 |
| 2024-12-31 | $17.64M 10-K · filed 2026-03-10 |
| 2024-09-30 | $14.94M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $14.70M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $15.28M 10-Q · filed 2024-05-07 |
| 2023-12-31 | $15.06M 10-K · filed 2025-03-11 |
| 2023-09-30 | $9.49M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $8.81M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $6.96M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $6.86M 10-K · filed 2024-03-12 |
| 2022-09-30 | $7.01M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $7.79M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $9.84M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $13.59M 10-K · filed 2023-03-16 |
| 2021-09-30 | $5.84M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $7.04M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $7.92M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $8.69M 10-K · filed 2022-03-08 |
| 2020-09-30 | $4.09M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $3.98M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $4.39M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $4.90M 10-K · filed 2021-03-10 |
| 2019-09-30 | $8.53M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $8.72M 10-Q · filed 2019-08-09 |
| 2018-12-31 | $9.06M 10-K · filed 2020-03-11 |
| 2018-09-30 | $7.58M 10-Q · filed 2018-11-08 |
| 2018-06-30 | $9.00M 10-Q · filed 2018-08-08 |
| 2017-12-31 | $8.28M 10-K · filed 2019-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |